| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |